• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HSP
Click for more information
0.00% $6.02

HEALTHSCOPE LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
HSPChange of Director's Interest Notice01/09/09
HSPChange of Director's Interest Notice01/09/09
HSPHealthscope completes institutional placementPRICE SENSITIVE27/08/09
HSPAppendix 3B27/08/09
HSPAustralian OvPlex distributor acquired by HealthscopePRICE SENSITIVE26/08/09
HSPFY 2009 Results Presentation26/08/09
HSPJune 2009 Full year Market ReleasePRICE SENSITIVE26/08/09
HSPAppendix 4E FY 2009 Annual AccountsPRICE SENSITIVE26/08/09
HSPTrading HaltPRICE SENSITIVE26/08/09
HSPChange of Director's Interest Notice21/08/09
HSPAppendix 3B20/08/09
HSPHealthscope Commcences New Pathology Operations in Auckland10/08/09
HSPAMCHAM Presentation - Asia Healthcare Markets05/08/09
HSPChange of Registered Office13/07/09
HSPBreak Fee LitigationPRICE SENSITIVE10/07/09
HSPSymbion Health Break Fee LitigationPRICE SENSITIVE09/07/09
HSPChange of Director's Interest Notice01/06/09
HSPInitial Director's Interest Notice15/05/09
HSPChange of Director's Interest Notice12/05/09
HSPAppendix 3B Performance Rights11/05/09
HSPMacquarie Emerging Leaders Conference Presentation 7 May 0907/05/09
HSPForm 604 Change of Interests of Substantial Holder from SUN28/04/09
HSPChange of Director's Interest Notice28/04/09
HSPSingapore-Malaysia Investor Presentations 200928/04/09
HSPAppointment of Non Executive Director - Amended22/04/09
HSPAppointment of Non-Executive Director22/04/09
HSPForm 604 Change of Interests of Substantial Holder from SUN16/04/09
HSPChange of Director's Interest Notice06/04/09
HSPChange of Director's Interest Notice06/04/09
HSPAppendix 3B06/04/09
HSPChange of Director's Interest Notice13/03/09
HSPHealthscope Dividend Reinvestment Share Price12/03/09
HSP +Healthscope to Commence Auckland Pathology Contract 7.9.0906/03/09
HSPChange of Director's Interest Notice25/02/09
CIR +Circadian and Healthscope to commercialise cancer diagnosticPRICE SENSITIVE25/02/09
HSPHY Dec 2008 Results Presentatiion19/02/09
HSPHalf Yearly Report and AccountsPRICE SENSITIVE19/02/09
HSPDecember 2008 Half Year Market Release19/02/09
HSP +Auckland Community Pathology ContractPRICE SENSITIVE12/02/09
HSP +Healthscope chooses iSOFT solutions for its hospitalsPRICE SENSITIVE27/01/09
HSPCeasing to be a substantial holder06/01/09
HSP +CerviScreen Agreement AnnouncementPRICE SENSITIVE18/12/08
AXA +Change in substantial holding from AXA17/12/08
HSPAppendix 3Y28/11/08
HSPChange of Director's Interest Notice
01/09/09
HSPChange of Director's Interest Notice
01/09/09
HSPHealthscope completes institutional placement
27/08/09PRICE SENSITIVE
HSPAppendix 3B
27/08/09
HSPAustralian OvPlex distributor acquired by Healthscope
26/08/09PRICE SENSITIVE
HSPFY 2009 Results Presentation
26/08/09
HSPJune 2009 Full year Market Release
26/08/09PRICE SENSITIVE
HSPAppendix 4E FY 2009 Annual Accounts
26/08/09PRICE SENSITIVE
HSPTrading Halt
26/08/09PRICE SENSITIVE
HSPChange of Director's Interest Notice
21/08/09
HSPAppendix 3B
20/08/09
HSPHealthscope Commcences New Pathology Operations in Auckland
10/08/09
HSPAMCHAM Presentation - Asia Healthcare Markets
05/08/09
HSPChange of Registered Office
13/07/09
HSPBreak Fee Litigation
10/07/09PRICE SENSITIVE
HSPSymbion Health Break Fee Litigation
09/07/09PRICE SENSITIVE
HSPChange of Director's Interest Notice
01/06/09
HSPInitial Director's Interest Notice
15/05/09
HSPChange of Director's Interest Notice
12/05/09
HSPAppendix 3B Performance Rights
11/05/09
HSPMacquarie Emerging Leaders Conference Presentation 7 May 09
07/05/09
HSPForm 604 Change of Interests of Substantial Holder from SUN
28/04/09
HSPChange of Director's Interest Notice
28/04/09
HSPSingapore-Malaysia Investor Presentations 2009
28/04/09
HSPAppointment of Non Executive Director - Amended
22/04/09
HSPAppointment of Non-Executive Director
22/04/09
HSPForm 604 Change of Interests of Substantial Holder from SUN
16/04/09
HSPChange of Director's Interest Notice
06/04/09
HSPChange of Director's Interest Notice
06/04/09
HSPAppendix 3B
06/04/09
HSPChange of Director's Interest Notice
13/03/09
HSPHealthscope Dividend Reinvestment Share Price
12/03/09
HSP +Healthscope to Commence Auckland Pathology Contract 7.9.09
06/03/09
HSPChange of Director's Interest Notice
25/02/09
CIR +Circadian and Healthscope to commercialise cancer diagnostic
25/02/09PRICE SENSITIVE
HSPHY Dec 2008 Results Presentatiion
19/02/09
HSPHalf Yearly Report and Accounts
19/02/09PRICE SENSITIVE
HSPDecember 2008 Half Year Market Release
19/02/09
HSP +Auckland Community Pathology Contract
12/02/09PRICE SENSITIVE
HSP +Healthscope chooses iSOFT solutions for its hospitals
27/01/09PRICE SENSITIVE
HSPCeasing to be a substantial holder
06/01/09
HSP +CerviScreen Agreement Announcement
18/12/08PRICE SENSITIVE
AXA +Change in substantial holding from AXA
17/12/08
HSPAppendix 3Y
28/11/08
refresh Created with Sketch. REFRESH
 

Top Stories

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Adavale Resources Ltd has entered into an all-scrip acquisition of the Parkes gold and copper project in New South Wales
Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia New Zealand’s Reserve Bank has taken a bold step, slashing rates by 50 basis points to 4.25% @ its third cut in just four months. Meanwhile, the Reserve Bank of Australia holds firm at 4.35%, its highest rate in over a decade.This stark policy divergence highlights contrasting glo...
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher Vitrafy Life Sciences Limited (ASX:VFY) has defied this month’s odds to become the only newly-listed Australian company to survive a surprisingly rough November (for newcomers, at least) without sagging below its IPO price.The cryopreservation biotech did give some back on Friday,...
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.